XRCC2 and XRCC3 polymorphisms are not associated with risk of colorectal adenoma.
Tranah
Gregory J
GJ
Department of Epidemiology, and Harvard Center for Cancer Prevention, Harvard School of Public Health, Boston, MA, USA.
Giovannucci
Edward
E
Ma
Jing
J
Fuchs
Charles
C
Hankinson
Susan E
SE
Hunter
David J
DJ
D000236:Adenoma / Q000453:epidemiology / Q000235:genetics*; D000428:Alcohol Drinking / Q000009:adverse effects; D016022:Case-Control Studies; D015179:Colorectal Neoplasms / Q000453:epidemiology / Q000235:genetics*; D004268:DNA-Binding Proteins / Q000235:genetics*; D005492:Folic Acid / Q000097:blood; D005838:Genotype; D006801:Humans; D016015:Logistic Models; D009726:Nurses; D011110:Polymorphism, Genetic; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects
D004268:DNA-Binding Proteins; C110901:X-ray repair cross complementing protein 3; C113187:XRCC2 protein, human; D005492:Folic Acid